BAS Stock Analysis: BASF SE | XETRA
Chemicals | XETRA, Germany | Market Cap: 44.062m EUR | 12M Return: 25.5% | DE000BASF111 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 87.2M
Qual. Beats: 2
Rev. Trend: -92.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BASF SE is a German-headquartered global chemical company founded in 1865, operating across six business segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The companys portfolio spans the full chemical value chain, from petrochemicals and intermediates at the upstream end to specialized downstream offerings such as automotive coatings, battery materials, crop protection products, and ingredients for nutrition and personal care applications. BASF also has activities in commodity and renewable energy trading, engineering, and rental/leasing, with its headquarters located in Ludwigshafen am Rhein, Germany.
The company operates in the Commodity Chemicals sub-industry within the Materials sector, a segment characterized by high capital intensity, exposure to feedstock (oil and gas) price cycles, and demand that tends to track global industrial activity. Its broad product mix-covering industrial intermediates, specialty additives, and consumer-oriented chemicals-reflects a common strategy among large integrated chemical producers to balance higher-volume, price-sensitive commodity output with more differentiated, margin-stable specialty lines.
- European natural gas costs squeeze Ludwigshafen Verbund margins
- Agricultural Solutions faces generic crop protection pricing pressure
- China chemical demand weakness pressures volumes and segment earnings
| Net Income: 5.80b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.64 > 1.0 |
| NWC/Revenue: 29.02% < 20% (prev 21.83%; Δ 7.19% < -1%) |
| CFO/TA 0.06 > 3% & CFO 4.73b > Net Income 5.80b |
| Net Debt (18.7b) to EBITDA (7.72b): 2.42 < 3 |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (893.9m) vs 12m ago 0.15% < -2% |
| Gross Margin: 23.96% > 18% (prev 25.57%; Δ -1.61% > 0.5%) |
| Asset Turnover: 76.25% > 50% (prev 80.92%; Δ -4.67% > 0%) |
| Interest Coverage Ratio: 3.85 > 6 (EBIT TTM 4.14b / Interest Expense TTM 1.08b) |
| A: 0.21 (Total Current Assets 38.8b - Total Current Liabilities 20.9b) / Total Assets 83.9b |
| B: 0.38 (Retained Earnings 31.9b / Total Assets 83.9b) |
| C: 0.05 (EBIT TTM 4.14b / Avg Total Assets 80.8b) |
| D: 0.78 (Book Value of Equity 36.3b / Total Liabilities 46.5b) |
| Altman-Z'' = 3.80 = AA |
| DSRI: 0.87 (Receivables 12.4b/14.6b, Revenue 61.6b/62.9b) |
| GMI: 1.07 (GM 25.57% / 23.96%) |
| AQI: 0.89 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 0.98 (Revenue 61.6b / 62.9b) |
| TATA: 0.01 (NI 5.80b - CFO 4.73b) / TA 83.9b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of October 13, 2026, the stock is trading at EUR 51.27 with a total of 1,422,846 shares traded. Over the past week, the price has changed by +2.05%, over one month by -2.12%, over three months by +4.95% and over the past year by +25.47%.
Current recommended Stop Loss: 49.00 (which is 4.4% or 2.1 ATR below the current price).
BASF SE has no consensus analysts rating.
P/E Trailing = 21.325
P/E Forward = 17.8571
P/S = 0.7155
P/B = 1.2277
P/EG = 0.6871
Revenue TTM = 61.6b EUR
EBIT TTM = 4.14b EUR
EBITDA TTM = 7.72b EUR
Long Term Debt = 18.8b EUR (from longTermDebt, last quarter)
Short Term Debt = 6.18b EUR (from shortTermDebt, last quarter)
Debt = 26.6b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.55b
Net Debt = 18.7b EUR (calculated: Debt 26.6b - CCE 7.89b)
Enterprise Value = 62.7b EUR (44.1b + Debt 26.6b - CCE 7.89b)
Interest Coverage Ratio = 3.85 (Ebit TTM 4.14b / Interest Expense TTM 1.08b)
EV/FCF = 60.03x (Enterprise Value 62.7b / FCF TTM 1.04b)
FCF Yield = 1.67% (FCF TTM 1.04b / Enterprise Value 62.7b)
FCF Margin = 1.70% (FCF TTM 1.04b / Revenue TTM 61.6b)
Net Margin = 9.42% (Net Income TTM 5.80b / Revenue TTM 61.6b)
Gross Margin = 23.96% ((Revenue TTM 61.6b - Cost of Revenue TTM 46.8b) / Revenue TTM)
Gross Margin QoQ = 25.19% (prev 25.92%)
Tobins Q-Ratio = 0.75 (Enterprise Value 62.7b / Total Assets 83.9b)
Interest Expense / Debt = 4.05% (Interest Expense 1.08b / Debt 26.6b)
Taxrate = 29.96% (926.0m / 3.09b)
NOPAT = 2.90b (EBIT 4.14b * (1 - 29.96%))
Current Ratio = 1.85 (Total Current Assets 38.8b / Total Current Liabilities 20.9b)
Debt / Equity = 0.73 (Debt 26.6b / totalStockholderEquity, last quarter 36.3b)
Debt / EBITDA = 2.42 (Net Debt 18.7b / EBITDA 7.72b)
Debt / FCF = 17.87 (Net Debt 18.7b / FCF TTM 1.04b)
Total Stockholder Equity = 34.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.18% (Net Income 5.80b / Total Assets 83.9b)
RoE = 17.00% (Net Income TTM 5.80b / Total Stockholder Equity 34.1b)
RoCE = 7.82% (EBIT 4.14b / Capital Employed (Equity 34.1b + L.T.Debt 18.8b))
RoIC = 4.39% (NOPAT 2.90b / Invested Capital 66.1b)
WACC = 5.62% (E(44.1b)/V(70.6b) * Re(7.29%) + D(26.6b)/V(70.6b) * Rd(4.05%) * (1-Tc(0.30)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -24.36 | Cagr: 0.07%
[DCF] Terminal Value 77.97% ; FCFF base≈814.2m ; Y1≈933.3m ; Y5≈1.37b
[DCF] Fair Price = 2.32 (EV 20.7b - Net Debt 18.7b = Equity 2.00b / Shares 860.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.42 | # QB: 2
Revenue Correlation: -92.21 | Revenue CAGR: -5.22% | SUE: 0.50 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.39 | Chg30d=+1.50% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=3.02 | Chg30d=+0.18% | Revisions=+22% | GrowthEPS=+34.6% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=2.96 | Chg30d=-0.51% | Revisions=-30% | GrowthEPS=-1.8% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: +0% (up=7, down=7)